Abstract
Background/Aims: First line palliative chemotherapy (CT1) improves sur- vival and quality of life in advanced biliary cancer (ABC). There is no randomised evidence to support second line chemotherapy (CT2) in ABC. We reviewed the experience of CT2 in ABC at four NSW cancer centres.
Cite
CITATION STYLE
APA
Kim, H. J., Yun, J., Kim, H. J., Kim, K. H., Kim, S. H., Lee, S.-C., … Hong, D. S. (2015). Second-Line Chemotherapy in Advanced Biliary Tract Cancer: A Retrospective Analysis. Soonchunhyang Medical Science, 21(2), 75–81. https://doi.org/10.15746/sms.15.017
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free